These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15818468)

  • 1. Decision-making at the surface of the intact or barrier disrupted skin: potential applications for vaccination or therapy.
    Partidos CD; Muller S
    Cell Mol Life Sci; 2005 Jul; 62(13):1418-24. PubMed ID: 15818468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcutaneous and intradermal vaccination.
    Combadiere B; Liard C
    Hum Vaccin; 2011 Aug; 7(8):811-27. PubMed ID: 21817854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Skin vaccination].
    Naito S
    Nihon Rinsho; 2008 Oct; 66(10):1888-93. PubMed ID: 18939486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initiation of adaptive immune responses by transcutaneous immunization.
    Warger T; Schild H; Rechtsteiner G
    Immunol Lett; 2007 Mar; 109(1):13-20. PubMed ID: 17320194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dendritic cells of mucosa and skin: "recruited for vaccination"].
    Le Borgne M; Dubois B; Kaiserlian D
    Med Sci (Paris); 2007 Oct; 23(10):819-25. PubMed ID: 17937889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applying peptide antigens onto bare skin: induction of humoral and cellular immune responses and potential for vaccination.
    Partidos CD; Beignon AS; Brown F; Kramer E; Briand JP; Muller S
    J Control Release; 2002 Dec; 85(1-3):27-34. PubMed ID: 12480308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frontiers of transcutaneous vaccination systems: novel technologies and devices for vaccine delivery.
    Matsuo K; Hirobe S; Okada N; Nakagawa S
    Vaccine; 2013 May; 31(19):2403-15. PubMed ID: 23523401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiphoton high-resolution 3D imaging of Langerhans cells and keratinocytes in the mouse skin model adopted for epidermal powdered immunization.
    Mulholland WJ; Arbuthnott EA; Bellhouse BJ; Cornhill JF; Austyn JM; Kendall MA; Cui Z; Tirlapur UK
    J Invest Dermatol; 2006 Jul; 126(7):1541-8. PubMed ID: 16645596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine therapy for cutaneous T-cell lymphoma.
    Seo N; Furukawa F; Tokura Y; Takigawa M
    Hematol Oncol Clin North Am; 2003 Dec; 17(6):1467-74. PubMed ID: 14710897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The skin as an immune organ.
    Salmon JK; Armstrong CA; Ansel JC
    West J Med; 1994 Feb; 160(2):146-52. PubMed ID: 8160465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical vaccination of DNA antigens: topical delivery of DNA antigens.
    Choi MJ; Maibach HI
    Skin Pharmacol Appl Skin Physiol; 2003; 16(5):271-82. PubMed ID: 12907832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insight into the immunobiology of human skin and functional specialization of skin dendritic cell subsets to innovate intradermal vaccination design.
    Teunissen MB; Haniffa M; Collin MP
    Curr Top Microbiol Immunol; 2012; 351():25-76. PubMed ID: 21833835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tailored immunity by skin antigen-presenting cells.
    Levin C; Perrin H; Combadiere B
    Hum Vaccin Immunother; 2015; 11(1):27-36. PubMed ID: 25483512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responses.
    Anjuère F; George-Chandy A; Audant F; Rousseau D; Holmgren J; Czerkinsky C
    J Immunol; 2003 Feb; 170(3):1586-92. PubMed ID: 12538724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging skin-targeted drug delivery strategies to engineer immunity: A focus on infectious diseases.
    Korkmaz E; Balmert SC; Carey CD; Erdos G; Falo LD
    Expert Opin Drug Deliv; 2021 Feb; 18(2):151-167. PubMed ID: 32924651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Needle-free epidermal powder immunization.
    Chen D; Maa YF; Haynes JR
    Expert Rev Vaccines; 2002 Oct; 1(3):265-76. PubMed ID: 12901567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis.
    Takigawa M; Tokura Y; Hashizume H; Yagi H; Seo N
    Ann N Y Acad Sci; 2001 Sep; 941():139-46. PubMed ID: 11594567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermal enhancement: bacterial products on intact skin induce and augment organ-specific autoimmune disease.
    Riminton DS; Kandasamy R; Dravec D; Basten A; Baxter AG
    J Immunol; 2004 Jan; 172(1):302-9. PubMed ID: 14688338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvants in cutaneous vaccination: A comprehensive analysis.
    Oladejo M; Tijani AO; Puri A; Chablani L
    J Control Release; 2024 May; 369():475-492. PubMed ID: 38569943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on the use of laser technology in skin vaccination.
    Chen X; Wang J; Shah D; Wu MX
    Expert Rev Vaccines; 2013 Nov; 12(11):1313-23. PubMed ID: 24127871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.